Trial Profile
Riociguat Pharmacokinetics in Healthy Young Chinese Male Non-Smokers and Smokers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Riociguat (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Pharmacokinetics
- 03 Nov 2015 New trial record
- 26 Oct 2015 Results published in Clinical Pharmacokinetics